NCT07909486Recruiting
Identification of Biomarkers for Vagus Nerve Stimulation in Patients With Refractory Epilepsy
Source: ClinicalTrials.gov · Last updated 2 Nov 2026
Brief summary (registry, in English)
A VNS longitudinal study focused on pre and post-VNS implantation in order to predict the VNS response and to understand better mechanisms of VNS using some connectivity and network measures.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 4 Dec 2023
- Start date
- 28 Feb 2022
- Primary completion date
- 1 Sept 2025
- Lead sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Diseases
- Epilepsy
- NCT number
- NCT07909486
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 28 Feb 2022 to the primary completion date, 1 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concomitant laryngeal pathology (e.g. recurrent nerve lesions, vocal fold paralysis).
Other illness
- Dementia/ Neurodegenerative diseases
Who the study is looking for
- Patients aged \>18 years
- Intelectual Quotient \>55 on Wechsler scale (normal or mild cognitive impairment)
- Patients have refractory epilepsy and are planned for VNS implantation
Age in the registry: 18 years to 79 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Clinique Universitaires Saint-Luc Coordinator of this site? Confirm its status | Brussels | Belgium | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.